AHRA cancels upcoming conference in San Diego amid COVID-19 worries

The Association for Medical Imaging Management has canceled its 2020 spring conference due to the coronavirus outbreak, the group announced March 6. The annual gathering was set to kick off on March 28 in San Diego.

The AHRA is the latest medical society to cancel or postpone its annual conference as COVID-19 continues to spread into the U.S. In the past few weeks, the Healthcare Information and Management Systems Society, Society of Interventional Radiology, American Board of Radiology, American College of Cardiology and many others made the move to cancel upcoming meetings or exams.

According to the AHRA’s announcement, registrants have the option to receive a refund or exchange their spring conference registration for the society’s annual meeting and exposition scheduled for July 12-15 in Boston.

“The health and well-being of our meeting attendees, staff, vendors, and the AHRA community are our primary concern,” AHRA President, Chris Tomlinson said in a statement. “Additionally, many AHRA members who are frontline medical imaging managers and critical to their health organization’s operations are not permitted any non-essential travel at this time. We believe it’s important that key healthcare leaders aren’t displaced during a critical time.”

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.